Akèy › Dyabèt Tip 2 › Kentucky
Etid klinik pou Dyabèt Tip 2 nan Kentucky
12 etid pou Dyabèt Tip 2 ap chèche patisipan nan sit nan Kentucky.
Vil nan Kentucky
Tèks ofisyèl etid la (Anglè)
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
- AMR Lexington, Lexington
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07754461EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Qualmedica Research - Bowling Green, Bowling Green
- The Research Group of Lexington, Lexington
- Research Integrity, LLC, Owensboro
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07064473A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
- St Elizabeth Health Care - CRI, Edgewood
- UofL Health, Louisville
Ap rekriteVolontè an sante akeyi
Laj 55 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT06112418A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- Monroe Biomedical Research, Louisville
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07595549A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
- Research Site, Bowling Green
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT07662213Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
- St. Elizabeth Healthcare, Edgewood
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT07296484AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
- The Research Group of Lexington LLC, Lexington
Ap rekriteFaz 3
Laj 45 ak plis · Tout sèks · Mizajou Sep 1, 2026 · NCT07797335A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus
- Research Site, Lexington
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 31, 2026 · NCT07662044A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
- Norton Children's Endocrinology, Louisville
Ap rekriteFaz 3
Laj 10 a 17 · Tout sèks · Mizajou Aug 7, 2026 · NCT06739122Time-restricted Eating for Patients With Type 2 Diabetes
- University of Kentucky Barnstable Brown Diabetes Center, Lexington
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jul 31, 2026 · NCT07318207OASIS: Peer Support for T2DM in Appalachia (Peer Participant)
- Barren River Area Development District, Bowling Green
- UK HealthCare, Hazard
Ap rekrite
Laj 55 ak plis · Tout sèks · Mizajou Jun 17, 2026 · NCT06336122OASIS: Peer Support for T2DM in Appalachia (Peer Coaches)
- Barren River Area Development District, Bowling Green
- UK HealthCare, Hazard
Ap rekrite
Laj 55 ak plis · Tout sèks · Mizajou Jun 17, 2026 · NCT06003634Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.